Categories: Uncategorized

A Patient with Fever and Dyspnea


an objective

After evaluating this interactive medical case, participants should be able to confirm or demonstrate an increase in their knowledge of clinical medicine. Participants should be able to evaluate the suitability of clinical information as it applies to patients’ care.

Credit

The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Massachusetts Medical Society designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim credit only with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the assessment component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equal to the amount of CME credit claimed for the activity. It is the responsibility of the CME activity provider to provide complete information to the participant for the purpose of awarding ABIM MOC credit.

You must score 100% to achieve AMA PRA Category 1 Credit™. Once you successfully complete the exam, you can claim your credit for the exam.

Duration: Issued on November 5, 2020, and valid for credit from that date until November 5, 2022.

Learning Objectives

Upon completion of this activity, the participant is able to describe some features of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identify the drug recommended for the treatment of severe SARS-CoV-2 infection Should be

Program disclosures

Carla S. Rothaus, MD (Editor, NEJM Weekly CME Program) and Julie R. Ingelinger, MD (Deputy Editor, NEJM) report that they have no financial relationships or interests to disclose.

Article disclosure

Dr. Vaidya reports receiving consultancy fees from Catalys Pacific, Corresp Therapeutics and HRAPharma, and grant support from the National Institutes of Health and Venus Charitable Foundation. No other potential conflict of interest relevant to this article was stated.

Disclosure forms provided by the authors are available at NEJM.org along with the full text of this article.

Target audience

This activity was developed for family physicians, general practitioners, physicians, and other health care providers.

Contact

If you have any questions about this educational activity, please contact the MMS Department of Education and the Certification Department at 800-322-2303. 7306, or on [email protected]



Source link

sony

Share
Published by
sony

Recent Posts

Environmental Factor – August 2017: Remembering children’s health champion Herbert Needleman

Herbert Needleman, MD, a physician-scientist whose lead in consumer products was removed due to research…

1 month ago

Environmental Factor – August 2017: FARE awards recognize 17 NIEHS fellows for outstanding research

ਸਤਾਰਾਂ ਐਨਆਈਈਐਚਐਸ ਫੈਲੋਜ਼ ਨੂੰ 199 ਨੈਸ਼ਨਲ ਇੰਸਟੀਚਿ ofਟ ਆਫ਼ ਹੈਲਥ (ਐਨਆਈਐਚ) ਦੇ ਖੋਜਕਰਤਾਵਾਂ ਵਿੱਚ ਖੋਜ…

1 month ago

Extramural Papers of the Month

(ਹੋਰ ਪੜ੍ਹੋ) Source link

1 month ago

Environmental Factor – January 2021: Woychik shares leadership philosophy and goals

In this inaugural director’s column, I would like to share with you what makes me…

1 month ago

Induction of Fetal Hemoglobin by Gene Therapy

Shortly after birth, fetal hemoglobin is replaced by adult hemoglobin in red cells, a process…

1 month ago

Treatment by CRISPR-Cas9 Gene Editing — A Proof of Principle

As a tool of great promise for the treatment of inherited human diseases, the clustered…

1 month ago